Skip to Content

CP 419 (Aspirin, Caffeine, and Dihydrocodeine Bitartrate 356.4 mg / 30 mg / 16 mg)

Pill with imprint CP 419 is Blue & Gray, Capsule-shape and has been identified as Aspirin, caffeine, and dihydrocodeine bitartrate 356.4 mg / 30 mg / 16 mg. It is supplied by Sun Pharmaceutical Industries Inc..

Aspirin/caffeine/dihydrocodeine is used in the treatment of pain and belongs to the drug class narcotic analgesic combinations. FDA has not classified the drug for risk during pregnancy. Aspirin/caffeine/dihydrocodeine 356.4 mg / 30 mg / 16 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for CP 419

Aspirin, caffeine, and dihydrocodeine bitartrate

CP 419
356.4 mg / 30 mg / 16 mg
Blue & Gray
Prescription only
Drug Class:
Narcotic analgesic combinations
Pregnancy Category:
N - Not classified
CSA Schedule:
3 - Moderate abuse potential
Labeler / Supplier:
Sun Pharmaceutical Industries Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.